US President's Emergency Plan for AIDS Relief (PEPFAR), the global HIV response has entered a second year of structural transformation. In early 2025, the programme faced the most uncertain period in ...
The US has committed a $5.88-billion spending package to the global response to HIV, one year after severe Pepfar funding ...
The R26 billion is expected to be shared among provinces. “R26 billion is allocated to provinces to bolster our HIV/Aids ...
The Global Fund has committed an additional Sh256 million ($2 million) to support Kenya’s rollout of the long-acting HIV prevention injection, Lenacapavir.
Finance Minister Enoch Godongwana revealed a significant R26 billion allocation to enhance HIV/AIDS programmes, alongside R410 million redirected to sustain vital research funding.
The massive cuts to science, global health, and HIV programs that unfolded in 2025 triggered a crisis with worldwide repercussions. The dissolution of USAID, the shutdown of PEPFAR, and the suspension ...
Finance Minister Enoch Godongwana revealed a significant R26 billion allocation to enhance HIV/AIDS programmes, alongside R410 million redirected to sustain vital research funding.
A new study led by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) finds that the ...
Zimbabwe has launched lenacapavir, an HIV prevention drug administered biannually, aiming to curb infections. While offering hope for at-risk groups, obstacles include funding and infrastructure. The ...
Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is ...
A single-pill treatment to suppress HIV proved as effective as existing therapies of up to 11 tablets daily, the latest advance in a scientific “golden age” for treating the virus even as rich ...